Mario Delgado Selected Research

Interleukin-6 (Interleukin 6)

11/2021	Silyl resveratrol derivatives as potential therapeutic agents for neurodegenerative and neurological diseases.
1/2003	Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.
1/2002	Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.
1/2002	Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Delgado Research Topics

Disease

27	Inflammation (Inflammations) 01/2022 - 08/2002
23	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2002
15	Rheumatoid Arthritis 01/2017 - 01/2003
11	Immune System Diseases (Immune Disorders) 09/2015 - 06/2007
11	Experimental Arthritis 01/2015 - 03/2006
10	Multiple Sclerosis 07/2022 - 05/2003
10	Arthritis (Polyarthritis) 01/2017 - 05/2003
9	Colitis 01/2022 - 04/2003
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2022 - 09/2005
7	Parkinson Disease (Parkinson's Disease) 01/2024 - 05/2003
7	Sepsis (Septicemia) 12/2022 - 09/2006
7	Crohn Disease (Crohn's Disease) 03/2009 - 04/2003
7	Septic Shock (Toxic Shock Syndrome) 01/2007 - 01/2002
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2022 - 03/2006
5	Pain (Aches) 12/2022 - 05/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 01/2003
5	Fibrosis (Cirrhosis) 01/2022 - 01/2002
5	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2009 - 05/2006
4	Weight Loss (Weight Reduction) 02/2018 - 04/2003
3	Neuroinflammatory Diseases 01/2024 - 01/2013
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2022 - 11/2021
3	Neoplasms (Cancer) 07/2022 - 05/2006
3	Hyperalgesia 06/2021 - 05/2013
3	Atherosclerotic Plaque (Atheroma) 01/2018 - 05/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 10/2003
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2007 - 05/2003
3	Diarrhea 12/2006 - 03/2006
3	Leukemia 12/2006 - 05/2006
3	Peritonitis 01/2002 - 01/2002
2	Chronic Disease (Chronic Diseases) 12/2022 - 03/2009
2	Virus Diseases (Viral Diseases) 07/2022 - 07/2006
2	Huntington Disease (Huntington's Disease) 11/2021 - 02/2018
2	Atherosclerosis 01/2018 - 01/2017
2	Myocarditis (Carditis) 01/2018 - 01/2017
2	Cardiomegaly (Heart Hypertrophy) 01/2018 - 01/2017
2	Vascular Calcification 01/2017 - 05/2013
2	Hypersensitivity (Allergy) 07/2006 - 12/2005
2	Endotoxemia 06/2006 - 03/2006
2	Body Weight (Weight, Body) 05/2006 - 03/2006
2	Shock 10/2003 - 01/2002
1	Movement Disorders (Movement Disorder) 01/2024
1	Mental Disorders (Mental Disorder) 07/2022
1	Demyelinating Diseases (Demyelinating Disease) 07/2022
1	Encephalomyelitis (Myeloencephalitis) 07/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Pathologic Processes 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022

Drug/Important Bio-Agent (IBA)

31	NeuropeptidesIBA 01/2024 - 01/2002
23	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2018 - 04/2003
22	Therapeutic UsesIBA 01/2018 - 04/2003
18	cortistatinIBA 01/2024 - 03/2006
17	CytokinesIBA 11/2021 - 01/2002
9	Peptides (Polypeptides)IBA 12/2022 - 03/2006
8	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2007 - 01/2002
6	Sulfonic AcidsIBA 01/2017 - 04/2003
5	AntigensIBA 03/2009 - 03/2006
4	Proteins (Proteins, Gene)FDA Link 07/2022 - 10/2007
4	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2002
4	Ghrelin ReceptorsIBA 11/2021 - 05/2007
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2021 - 05/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 01/2002
3	EndotoxinsIBA 11/2021 - 03/2006
3	Analgesics (Analgesic Drugs)IBA 06/2021 - 05/2013
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2008 - 01/2002
3	UrocortinsIBA 05/2008 - 06/2006
3	ChemokinesIBA 04/2008 - 01/2002
3	Neuroprotective AgentsIBA 10/2005 - 05/2003
2	ProdrugsIBA 12/2022 - 02/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 11/2021
2	3-nitropropionic acidIBA 11/2021 - 02/2018
2	ApolipoproteinsIBA 01/2018 - 01/2017
2	Collagen Type II (Type II Collagen)IBA 01/2017 - 01/2015
2	sym-trinitrobenzeneIBA 01/2017 - 01/2014
2	LipidsIBA 01/2017 - 10/2008
2	Dextran SulfateIBA 01/2017 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 08/2013 - 02/2007
2	GhrelinIBA 06/2008 - 05/2006
2	HMGB1 Protein (HMG1)IBA 06/2008 - 05/2008
2	DNA (Deoxyribonucleic Acid)IBA 05/2008 - 07/2006
2	(N- Ac- His(1)- Nle(17)- Arg(20,21)- Ala(26))- vasoactive intestinal peptideIBA 11/2007 - 12/2006
2	cortistatin AIBA 05/2007 - 03/2006
2	AdrenomedullinIBA 01/2007 - 06/2006
2	Immunomodulating AgentsIBA 06/2006 - 03/2006
2	AlbuminsIBA 01/2005 - 01/2002
2	Interleukin-12 (IL 12)IBA 01/2003 - 01/2002
1	Phosphotransferases (Kinase)IBA 01/2024
1	Leucine (L-Leucine)FDA Link 01/2024
1	vafidemstatIBA 07/2022
1	Conditioned Culture MediaIBA 01/2022
1	AP 1903 reagentIBA 01/2022

Therapy/Procedure

20	Therapeutics 01/2024 - 01/2002
7	Ligation 01/2022 - 03/2006
5	Punctures 08/2013 - 03/2006
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2006 - 05/2006
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2002 - 01/2002
2	Oral Administration 07/2022 - 01/2014
2	Homologous Transplantation 05/2009 - 05/2006
2	Transplantation 09/2007 - 06/2007
1	Drug Therapy (Chemotherapy) 01/2022